Jin Jun Luo, MD, PhD, MHA, FAAN, FAANEM
Editor-in-Chief: JNEN Lewis Katz School of Medicine, Temple University, USA
Frequency: Bi-annual
ISSN: 2469-407X
Abstracted/Indexed in:
SHERPA/RoMEO, Genamics, J-Gate, Index Copernicus, Scilit and Google Scholar
Digital Preservation in PORTICO
Jin Jun Luo
The Editorial Board of the Journal of Neurology and Experimental Neuroscience (JNEN) mourns the loss of Professor Nae Jiuun Dun, PhD, our esteemed Co-Editor-in-Chief, distinguished neuroscientist, mentor, and friend, who passed away peacefully on April 7, 2026, in Danville, California, USA, at the age of 80 after a courageous battle with a neurodegenerative disorder.
Jin Jun Luo
Idiopathic hypersomnia (IH) is a chronic central hypersomnolence disorder that impairs daily functioning and quality of life. Lacking definitive biomarkers, IH is frequently misdiagnosed or mistaken for psychiatric conditions. Diagnostic challenges include the limited specificity of the multiple sleep latency test (MSLT) in distinguishing IH from narcolepsy type 2 (NT2).
Dr. Musa Absi, Dr. Jonathan Iliff and Dr. Rayhan Ghanchi
Community treatment orders (CTOs) remain one of the most contested instruments in contemporary mental health law, sitting at the intersection of relapse prevention, constrained resources, and rights-based practice. Recent work from 2020 continues to show mixed population level outcomes but also suggests that CTOs may offer benefits for selecting high-risk subgroups when embedded in comprehensive community care.
Sumith Reddy Atla, P Sonalika Reddy, Thatikonda Ganesh and Poorvi M Patill
The gut microbiota plays a crucial role in brain development and function, influencing various neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disabilities (ID). Dysbiosis, or an imbalance in the gut microbiota, has been linked to altered neuroinflammation, impaired blood-brain barrier (BBB) integrity, and changes in neurotransmitter production, all of which contribute to NDD pathophysiology.
Lin Zhang
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. Characterized by cognitive decline, behavioral changes, and impaired daily functioning, AD’s complex pathology-including amyloid-beta (Aβ) plaques and tau neurofibrillary tangles-has hindered accurate diagnosis and effective treatment. This mini review discusses current diagnostic advancements and therapeutic interventions aimed at addressing these challenges.